 A Cantor Fitzgerald analyst is incrementally bullish on shares of Anavex Life Sciences, Corp NASDAQ:AVXL after the release of Phase 2 data for the companys lead candidate. The Anavex Analyst: Charles Duncan, Ph.D. 